The European League Against Rheumatism (EULAR) has released updated recommendations for the management of RA. According to this latest guidance, treatment with disease-modifying anti-rheumatic drugs (DMARDs) should be initiated ...
Jul 3, 2013
0
0
Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true.
Apr 11, 2013
0
0
Hepatocellular carcinoma (HCC) is a common human disease and one of the main causes of cancer-related death. The angiogenesis inhibitor Sorafenib (SORA) is commonly used in the treatment of advanced HCC as a first-line drug.
Feb 7, 2024
0
0
A translational research team led by the National University of Singapore (NUS) has harnessed CURATE.AI, a powerful artificial intelligence (AI) platform, to treat a patient with advanced cancer, completely halting disease ...
Sep 4, 2018
0
6
When you open a carton of Neapolitan ice cream, how do you scoop? Maybe you grab some chocolate and strawberry together, or maybe you eat one flavor at a time. The three flavors are in there to satisfy the variation you need ...
Jan 17, 2022
0
3
In a new study, researchers at Karolinska Institutet show that the activation of specific cell surface proteins—cortisol, estrogen and vitamin A—in mice with human neuroblastoma cells results in the neuronal differentiation ...
Jul 25, 2022
0
22
(HealthDay)—For patients with diabetic macular edema, repeated ranibizumab treatment does not appear to be associated with impaired macular perfusion, according to a study published online March 1 in JAMA Ophthalmology.
Mar 7, 2018
0
12
Lifelong smoker Mike James had quit the habit for nearly three years when, through fluky circumstances, he found out that he had a small tumor in his right lung.
Apr 14, 2022
0
5
A new national clinical trial found HIV drug regimens that do not include efavirenz are effective as first-line antiretroviral therapy. The finding is important for patients who are not eligible for treatment with efavirenz, ...
Oct 6, 2014
0
0
Scientists from Università Cattolica in Rome, together with colleagues from the IIGM Foundation (part of Candiolo Institute at Turin), have discovered a new drug-resistance mechanism in breast cancer that leads to the formation ...
Oct 6, 2022
0
36
